Findings from Harvard School of Medicine Reveals New Findings on Implantable Cardioverter Defibrillator (Nursing Home Use After Implantable…

Findings from Harvard School of Medicine Reveals New Findings on Implantable Cardioverter Defibrillator (Nursing Home Use After Implantable Cardioverter-Defibrillator Implantation in Older Adults: Results from the National Cardiovascular Data ...)

By a News Reporter-Staff News Editor at Insurance Weekly News -- Researchers detail new data in Implantable Cardioverter Defibrillator. According to news reporting out of Boston, Massachusetts, by VerticalNews editors, research stated, "To evaluate the incidence and characteristics of nursing home (NH) use after implantable cardioverter-defibrillator (ICD) implantation. Cohort study. Medicare beneficiaries in the National Cardiovascular Data Registry-ICD Registry."

Funders for this research include Aging Research, National Institute on Aging, National Institutes of Health, Medical Device Epidemiology Network Methodology Center, Food and Drug Administration, American College of Cardiology Foundation.

Our news journalists obtained a quote from the research from the Harvard School of Medicine, "Individuals aged 65 and older receiving ICDs between January 1, 2006, and March 31, 2010 (N = 192,483). Proportion of ICD recipients discharged to NHs directly after device placement, cumulative incidence of long-term NH admission, and factors associated with immediate discharge to a NH and time to long-term NH admission. Over 4 years, 40.6% of the cohort died, and 35,939 (18.7%) experienced at least one NH admission, including 4.0% directly discharged to a NH after ICD implantation and 2.8% admitted to long-term NH care during follow-up. The cumulative incidence of long-term NH admission, accounting for the competing risk of death, was 1.7% at 1 year, 3.8% at 3 years, and 4.6% at 4 years; 20.1% of individuals admitted to a NH died there. Factors most strongly associated with direct NH discharge and time to long-term NH care were older age (adjusted odds ratio (AOR) = 2.09, 95% confidence interval (CI) = 2.01-2.17 per 10-year increment; adjusted hazard ratio (AHR) = 1.88, 95% CI = 1.80-1.97, respectively), dementia (AOR = 2.60, 95% CI = 2.25-3.01; AHR = 2.50, 95% CI = 2.14-2.93, respectively), and Medicare Part A claim for NH stay in prior 6 months (AOR = 3.96, 95% CI = 3.70-4.25; AHR = 2.88, 95% CI = 2.65-3.14, respectively). Nearly one in five individuals are admitted to NHs over a median of 1.6 years of follow-up after ICD implantation."

According to the news editors, the research concluded: "Understanding these outcomes may help inform the clinical care of these individuals."

For more information on this research see: Nursing Home Use After Implantable Cardioverter-Defibrillator Implantation in Older Adults: Results from the National Cardiovascular Data Registry. Journal of the American Geriatrics Society, 2017;65(2):340-347. Journal of the American Geriatrics Society can be contacted at: Wiley, 111 River St, Hoboken 07030-5774, NJ, USA. (Wiley-Blackwell - www.wiley.com/; Journal of the American Geriatrics Society - onlinelibrary.wiley.com/journal/10.1111/(ISSN)1532-5415)

Our news journalists report that additional information may be obtained by contacting D.B. Kramer, Harvard Med Sch, Boston, MA, United States. Additional authors for this research include M.R. Reynolds, S.L. Normand, C.S. Parzynski, J.A. Spertus, V. Mor and S.L. Mitchell.

Keywords for this news article include: Boston, Massachusetts, United States, North and Central America, Implantable Cardioverter Defibrillator, Medicare, Risk and Prevention, Medical Devices, Defibrillators, Cardiovascular, Health Policy, Cardiology, Surgery, Harvard School of Medicine.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC